Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

Immunoconjugates targeting cell-surface antigens have demonstrated clinical activity to enable regulatory approval in several solid and hematologic malignancies. We hypothesize that a rigorous and comprehensive surfaceome profiling approach to identify osteosarcoma-specific cell-surface antigens can...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yifei, Tian, Xiangjun, Zhang, Wendong, Zhang, Zhongting, Lazcano, Rossana, Hingorani, Pooja, Roth, Michael E., Gill, Jonathan D., Harrison, Douglas J., Xu, Zhaohui, Jusu, Sylvester, Kannan, Sankaranarayanan, Wang, Jing, Lazar, Alexander J., Earley, Eric J., Erickson, Stephen W., Gelb, Tara, Huxley, Philip, Lahdenranta, Johanna, Mudd, Gemma, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A., Kolb, Edward A., Gorlick, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Small Molecule Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167717/
https://www.ncbi.nlm.nih.gov/pubmed/35312779
http://dx.doi.org/10.1158/1535-7163.MCT-21-0836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167717/
https://www.ncbi.nlm.nih.gov/pubmed/35312779
http://dx.doi.org/10.1158/1535-7163.MCT-21-0836

Ejemplares similares